- C
- N
- O
Calculated reference model · not an experimental or batch-certified structure. All 11 atoms shown.
Model data & sources
- Heavy atoms only; hydrogens are omitted from the reference display.
- Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
- The source record leaves some stereochemistry unspecified. This calculated conformer does not establish a unique stereoisomer.
- Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
- Formula
- C6H10N2O3
- Method
- RDKit ETKDGv3 / MMFF94s calculated reference conformer
- Batch
- KC-OXR-02
Oxiracetam
NootropicsPublished formats
- Powder 50g
- Dry-Fill Capsule 120ct/400mg/48g
What is the difference between these?
- Powder
- Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
- Dry-Fill Capsule
- Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.
Pricing
Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.
Technical Specifications
Batch COA Database ↗Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.
Research Overview
Oxiracetam Research Standard
Oxiracetam (4-hydroxy-2-oxo-1-pyrrolidineacetamide) is a synthetic derivative of the piracetam family, characterized by the addition of a hydroxyl group to the pyrrolidone nucleus. This modification increases its potency compared to parent compounds, making it a staple in neuropharmacological research. Oxiracetam is primarily utilized as a specialized laboratory tool for investigating cognitive signaling pathways, specifically those related to cholinergic and glutamatergic neurotransmission, as well as cerebral energy metabolism in in vitro neural tissue models.
Physical & Handling Properties
| Property | Specification |
|---|---|
| Physical Appearance | Fine crystalline white or off-white powder |
Mechanism of Action & Research Context
Oxiracetam is studied for its ability to modulate key neurotransmitter systems and metabolic processes within the brain, particularly in contexts involving high-density neural information processing.
-
Cholinergic and Glutamatergic Modulation: Research indicates that oxiracetam may influence the release of acetylcholine and the modulation of glutamate receptors, which are essential for synaptic plasticity and the formation of long-term potentiation (LTP).
-
Metabolic Enhancement: The compound is evaluated for its capacity to optimize oxygen and glucose utilization pathways in neural tissues, potentially stabilizing ATP production in cell-based energy models.
-
Signaling Efficacy: By targeting these pathways, oxiracetam is used to measure the rate at which neural networks adapt and reorganize, providing a quantitative model for studying memory and learning efficiency.
Research Applications
Oxiracetam is a versatile reference compound utilized for exploring cognitive pathways in controlled laboratory settings.
Primary fields of in vitro laboratory investigation include:
-
Neurotransmitter Activity Mapping: Measuring glutamate-related signaling dynamics and cholinergic transmission in cultured hippocampal tissue.
-
Cellular Bioenergetics: Testing the compound’s influence on mitochondrial glucose uptake and oxygen consumption during metabolic stress.
-
Synaptic Plasticity: Observing the speed and fidelity of information storage/retrieval in controlled neuronal network models.
-
Cognitive Pharmacology: Serving as a benchmark for comparing the potency and activity profile of newer synthetic racetam derivatives.
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
References
-
Valzelli L, et al. (1980) "Oxiracetam: a psychotropic drug with learning-enhancing properties." Pharmacological Research Communications. 12(6): 579–583.
-
Malykh AG, Sadaie MR. (2010) "Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders." Drugs. 70(3): 287–312.
Related Research Compounds
Research Use Disclaimer
Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.
Certificates of Analysis
- Batch KC-OXR-02 3 reports
- Batch KC-OXR-01 2 reports
Currently shipping from batch KC-OXR-02.

Compounds That Survive Scrutiny
Research use only. Not for human or veterinary use.